Skip to main content
. 2018 Mar 30;67(4):606–613. doi: 10.1093/cid/ciy144

Table 1.

Participant Characteristics at Study Entry (N = 192)

Characteristic Total (n = 192) Perinatally HIV Infected (n = 93) HIV Uninfected (n = 99) P Value
Age, years 19 (18–20) 19 (17–20) 19 (18–20) .36
Ethnicity 1.0
 Thai 177 (92%) 86 (92%) 91 (92%)
 Vietnamese 15 (8%) 7 (8%) 8 (8%)
Living situation <.001
 One or both parents 84 (44%) 24 (26%) 60 (61%)
 Relatives 44 (23%) 33 (35%) 11 (11%)
 Partner 43 (22%) 24 (26%) 19 (19%)
 Alone 15 (8%) 8 (9%) 7 (7%)
 Other, did not answer 6 (3%) 4 (4%) 2 (2%)
Orphan status <.001
 Not an orphan 87 (45%) 13 (14%) 74 (75%)
 Maternal or paternal orphan 55 (29%) 34 (37%) 21 (21%)
 Double orphan 44 (23%) 41 (44%) 3 (3%)
 Unknown 6 (3%) 5 (5%) 1 (1%)
Current/highest education .36
 Primary school 20 (10%) 10 (11%) 10 (10%)
 Secondary school 141 (73%) 72 (77%) 69 (70%)
 Beyond secondary school 30 (16%) 11 (12%) 19 (19%)
Employment/school .003
 Currently working 73 (38%) 42 (45%) 31 (31%)
 In school 78 (41%) 41 (44%) 37 (37%)
 Neither 40 (21%) 10 (11%) 30 (30%)
Type of sexual relationships
 Female–Male 184 (99%) 88 (100%) 96 (99%) 1.00
 Female–Female 13 (7%) 8 (9%) 5 (5%) .39
 Did not answer 7 (4%) 5 (5%) 2 (2%)
Prior sexual activity by route
 Anal receptive 5 (3%) 4 (4%) 1 (1%) .20
 Oral receptive 42 (22%) 19 (21%) 23 (23%) .73
 Lifetime partners 2 (1–3) 2 (1–3) 2 (1–3) .76
 Partners in past 6 months 1 (1–1) 1 (1–1) 1 (1–1) .74
Monthly frequency of sex in past 3 months .34
 ≤5 times 107 (56%) 56 (60%) 51 (52%)
 6–10 times 32 (17%) 11 (12%) 21 (21%)
 11–20 times 13 (7%) 5 (5%) 8 (8%)
 >20 times 21 (11%) 11 (12%) 10 (10%)
 Did not answer 19 (10%) 10 (11%) 9 (9%)
Condom use with vaginal sex in past 6 months <.001
 Always 42 (22%) 31 (33%) 11 (11%)
 Sometimes 93 (48%) 50 (54%) 43 (43%)
 Never 52 (27%) 10 (11%) 42 (42%)
 No recent sex 5 (3%) 2 (2%) 3 (3%)
 Ever been pregnant 75 (39%) 31 (33%) 44 (44%) .14
Asymptomatic sexually transmitted infections at baseline
Chlamydia trachomatis 44 (23%) 24 (26%) 20 (20%) .39
Neisseria gonorrhoea 5 (3%) 5 (5%) 0 (0%) .03
 Syphilis 4/190 (2%) 2/92 (2%) 2/98 (2%) 1.0
 Herpes simplex virus 2 3 (2%) 0 (0%) 3 (3%) .25
Any cervical HPV 98 (51%) 58 (62%) 40 (40%) .003
 Any cervical HR HPV 69 (36%) 40 (43%) 29 (29%) .05
Any vaginal HPV 110/190 (58%) 62/91 (68%) 48 (48%) .01
 Any vaginal HR HPV 80/190 (42%) 45/91 (49%) 35 (35%) .06
Any anal HPV 94/191 (49%) 54 (58%) 40/98 (41%) .02
 Any anal HR HPV 62/191 (32%) 39 (42%) 23/98 (23%) .008
Any anogenital HPV 133 (69%) 74 (80%) 59 (60%) .003
 Any anogenital HR HPV 99 (52%) 56 (60%) 43 (43%) .02
Any oral HPV 18/190 (9%) 10/91 (11%) 8 (8%) .62
 Any oral HR HPV 9/190 (5%) 5/91 (5%) 4 (4%) .74

Characteristics are described as median (interquartile range or N [%]). Percentages are rounded and may not total 100%. Where test results were invalid or not performed, the denominator is shown.

Abbreviations: HIV, human immunodeficiency virus; HPV, human papillomavirus; HR, high risk.